By what mechanisms could prothrombin complex concentrates promote factor VIII bypassing activity in vivo?
Giles
A R
AR
Department of Pathology, Queen's University of Kingston, Ontario, Canada.
D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D005167:Factor VII / Q000502:physiology; D005169:Factor VIII / Q000502:physiology*; D006467:Hemophilia A / Q000188:drug therapy*; D049673:History, 20th Century; D006801:Humans; D010743:Phospholipids / Q000502:physiology
D001779:Blood Coagulation Factors; D010743:Phospholipids; C025667:prothrombin complex concentrates; D005167:Factor VII; D005169:Factor VIII